NCT07159035

Brief Summary

This study, known as the FLAME Trial (Flexible ureteroscopy for Lower pole stones And Mini-pErcutaneous nephrolithotomy), is an international, multicenter, randomized, non-inferiority trial. It aims to compare the effectiveness and safety of flexible ureteroscopy using a flexible and navigable suction ureteral access sheath (FANS) versus mini-percutaneous nephrolithotomy (mini-PCNL) in the treatment of 1-2 cm lower pole kidney stones. A total of 640 eligible adult patients will be enrolled across 20 high-volume urology centers in China, Russia, Turkey, and India. Participants will be randomly assigned to undergo either FANS-assisted flexible ureteroscopy or mini-PCNL. The primary outcome is the immediate stone-free rate (SFR) assessed by non-contrast CT within 72 hours after surgery. Secondary outcomes include SFR at 1 month, operative time, pain score, length of hospital stay, complication rates, and changes in health-related quality of life. The goal of this trial is to determine whether the less invasive FANS-assisted approach is non-inferior to mini-PCNL in terms of efficacy, while potentially offering advantages in postoperative recovery and safety.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
640

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 28, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

August 28, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 8, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2026

Completed
Last Updated

September 8, 2025

Status Verified

September 1, 2025

Enrollment Period

6 months

First QC Date

August 28, 2025

Last Update Submit

September 5, 2025

Conditions

Keywords

kidney stonesFANSPCNLRIRSflexible ureteroscopy

Outcome Measures

Primary Outcomes (1)

  • Immediate Stone-Free Rate (SFR)

    Stone-free status will be evaluated using non-contrast-enhanced computed tomography (NCCT) performed within 72 hours after surgery. Stone-free is defined as the absence of residual stone fragments or presence of clinically insignificant fragments ≤2 mm.

    72 hours after surgery

Secondary Outcomes (6)

  • Final Stone-Free Rate (SFR) at 1 Month

    1 month after surgery

  • Operative Time

    Intraoperative

  • Postoperative Pain Level

    Within 24 hours after surgery.

  • Length of Hospital Stay

    From the day of surgery until the day of discharge, assessed up to 30 days postoperatively.

  • Complication Rate Within 1 Month

    1 month after surgery.

  • +1 more secondary outcomes

Study Arms (2)

FANS-fURS Group

EXPERIMENTAL

Patients assigned to this group will undergo flexible ureteroscopy with FANS (Flexible endoscopy-Assisted Negative-pressure Suction Sheath). The FANS facilitates direct stone visualization, fragmentation, suction, and removal under controlled pressure conditions.

Procedure: Flexible ureteroscopy with FANS

mini-PCNL Group

ACTIVE COMPARATOR

Patients in this group will receive mini-percutaneous nephrolithotomy (mini-PCNL) via less than 20 Fr percutaneous tracts.

Procedure: Mini-percutaneous nephrolithotomy (mini-PCNL)

Interventions

The FANS with negative-pressure suction, enhancing intrarenal pressure control and fragment evacuation during flexible ureteroscopy.

FANS-fURS Group

Mini-PCNL is performed under general anesthesia with less than 20 Fr access tract, using rigid nephroscopy and stone fragmentation under direct visualization. Postoperative drainage is provided via nephrostomy or ureteral stent as per protocol.

mini-PCNL Group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18-75 years;
  • American Society of Anesthesiology (ASA) score 1-3;
  • Lower pole renal stones-single or multiple-with a maximal diameter of 1-2 cm confirmed by CT;
  • Ability to provide written informed consent and adhere to trial requirements.

You may not qualify if:

  • Significant urinary tract anatomical anomalies (e.g. horseshoe kidney, ileal conduit);
  • Stones located within a calyceal diverticulum;
  • History of open nephrolithotomy or ureterolithomy (due to resultant intrarenal anatomical distortion);
  • Absolute contraindications to either FANS-f-URS or mini-PCNL, including:
  • Uncorrectable coagulopathy;
  • Active, uncontrolled urinary tract infection;
  • Severe cardiopulmonary disease precluding safe general anesthesia (e.g. decompensated heart failure, refractory COPD);
  • Pregnancy;
  • Inability to tolerate lithotomy or prone positioning;
  • Inability to understand or complete trial documentation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, 510230, China

RECRUITING

Related Publications (2)

  • Skolarikos A, Geraghty R, Somani B, Tailly T, Jung H, Neisius A, Petrik A, Kamphuis GM, Davis N, Bezuidenhout C, Lardas M, Gambaro G, Sayer JA, Lombardo R, Tzelves L. European Association of Urology Guidelines on the Diagnosis and Treatment of Urolithiasis. Eur Urol. 2025 Jul;88(1):64-75. doi: 10.1016/j.eururo.2025.03.011. Epub 2025 Apr 22.

    PMID: 40268592BACKGROUND
  • Zhu W, Zhong J, Wang K, Yin G, Leung CH, Gadzhiev N, Gokce MI, Kalathia J, Gauhar V, Zhang G, Wu G, Li M, Fang L, Zeng S, Bai P, Li J, Zhao Z, Xi M, Mai X, Duan X, Jiang K, Cao J, Meng X, Liu S, Aloyan A, Yuan P, Zhu X, Huang T, Xing J, Du J, Wu W, Ma J, Zhong W, Zhao Z, Liu Y, Ng CF, de la Rosette J, Somani B, Qi S, Zeng G, Yuen SKK. Flexible ureteroscopy with a flexible and navigable suction ureteral access sheath versus mini-percutaneous nephrolithotomy for 1-2 cm lower pole renal stones: Protocol for an international, multicentre, randomized non-inferiority trial (FLAME trial). BJUI Compass. 2025 Nov 29;6(12):e70114. doi: 10.1002/bco2.70114. eCollection 2025 Dec.

MeSH Terms

Conditions

Kidney Calculi

Condition Hierarchy (Ancestors)

NephrolithiasisKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisUrinary CalculiMale Urogenital DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Central Study Contacts

Wei Zhu, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Blinding of participants and surgeons is not feasible due to the obvious procedural differences between flexible ureteroscopy with FANS and mini-percutaneous nephrolithotomy. However, radiologists assessing postoperative CT scans will be blinded to treatment allocation. Clinical follow-up assessments will be performed by independent investigators who did not participate in the surgeries. Statistical analysis will also be conducted in a blinded manner, with group assignments concealed from the analyst until data interpretation is complete.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomized in a 1:1 ratio to undergo either FANS-assisted flexible ureteroscopy or mini-percutaneous nephrolithotomy for the treatment of 1-2 cm lower pole renal stones. This is a multicenter, international, randomized, non-inferiority trial.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice-president

Study Record Dates

First Submitted

August 28, 2025

First Posted

September 8, 2025

Study Start

August 28, 2025

Primary Completion

February 28, 2026

Study Completion

March 31, 2026

Last Updated

September 8, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared due to institutional policy restrictions and data privacy considerations.

Locations